442
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Comparative effectiveness of vildagliptin in combination with other oral anti-diabetes agents in usual-care conditions: the EDGE–Latin America study

, , , , , & show all
Pages 1769-1776 | Accepted 21 May 2014, Published online: 11 Jun 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Charles Saab, Feryal A Al-Saber, Jihad Haddad, Mahir Khalil Jallo, Habib Steitieh, Giovanni Bader & Mohamed Ibrahim. (2015) Effectiveness and tolerability of second-line treatment with vildagliptin versus other oral drugs for type 2 diabetes in a real-world setting in the Middle East: results from the EDGE study. Vascular Health and Risk Management 11, pages 149-155.
Read now

Articles from other publishers (3)

Sérgio Vencio, Juan P. Manosalva, Chantal Mathieu, Pieter Proot, Hernan Yupanqui Lozno & Päivi M. Paldánius. (2021) Exploring early combination strategy in Latin American patients with newly diagnosed type 2 diabetes: a sub-analysis of the VERIFY study. Diabetology & Metabolic Syndrome 13:1.
Crossref
Li Zang, Yin Han, Lixian Chen, Daqing Hu, Hui Jin, Nailong Yang, Xiaoyun Shi, Linlang Liang, Mingming Liu, Hong Fan, Quanmin Li & Yiming Mu. (2019) Comparison of the Effectiveness and Safety of Vildagliptin Add-On to Metformin Versus Other Oral Dual Antidiabetes Agents in Patients with Type 2 Diabetes: The China Prospective Diabetes Study. Diabetes Therapy 10:4, pages 1391-1405.
Crossref
Omar Y. Bello-Chavolla & Carlos A. Aguilar-Salinas. 2017. Diabetes Mellitus in Developing Countries and Underserved Communities. Diabetes Mellitus in Developing Countries and Underserved Communities 101 126 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.